What the analyst said
UBS analyst Stephen Ju lowered the price target on Meta (NASDAQ: META) to $865.00 (from $908.00) while maintaining a Buy rating.
“Rather than interpreting the in-line 2Q26 revenue guidance as a signal that near-term GenAI benefits to core ad revenue is already priced in, we think there is still a case to make for upside surprise as: 1) impressions growth (+19% and up 1 ppt QOQ) has now resumed taking a larger role in driving revenue, and 2) Meta expects to deliver ongoing recommendation and ad engine improvements near term.
While the shares of its megacap peers have benefitted from recent deals and product announcements, Meta remains unique in that only the OpEx and CapEx has been placed in models, while the full extent of the revenue benefits remain to be determined.
We hence believe the optionality or positive change and hence a benefit to the multiple – which currently stands at 19x 2027 GAAP EPS – are ahead of us. Our OpEx and CapEx estimates do move higher, resulting in a 5% and 7% drop to our 2027E and 2028E EPS, respectively.
Our revised price target of $865 implies ~40% upside (vs aftermarket price) and we remain Buy rated.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
META trades at $618. The 33 analysts who set a target in the last 3 months range from $650 to $1,000, with a median of $850. This $865 target is 2% above the median.
Since the note META has moved −8% (from $669). 12-month window: day 201 of 365, closes on April 30, 2027.
Track record
This callOpen: META has not reached $865 yet. This 12-month target is scored on April 30, 2027.
Firm track recordUBS: 81% of its 54 targets at least a year old were reached within 12 months (#8 of 28 firms); on Meta, 3 of 7. Accuracy ranking →
UBS on Meta
UBS price targets on Meta
8 calls from October 9, 2025 to August 27, 2026. The target went from $900 to $715 (−21%). The rating stayed Buy.
- August 27, 2026Kept the $715 targetBuy$715
- July 30, 2026Target cut from $865 (−17%)Buy$715
- April 30, 2026 This noteTarget cut from $908 (−5%)Buy$865
- April 21, 2026Target raised from $872 (+4%)Buy$908
- January 29, 2026Target raised from $830 (+5%)Buy$872
- January 20, 2026Target cut from $915 (−9%)Buy$830
- October 30, 2025Target raised from $900 (+2%)Buy$915
- October 9, 2025Earliest call shownBuy$900





